<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE303nnn/GSE303020/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303020</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptome analysis of cells after SARS-CoV-2 infection and treatment with MEK1/2-inhibitor Zapnometinib.</name><description>Treatment of infected cells with MEK1/2-inhibitor Zapnometinib (named ATR here in treatments) significantly changed gene expression after infection with SARS-CoV-2 virus.</description><dates><publication>2026/05/18</publication></dates><accession>GSE303020</accession><cross_references><GSM>GSM9115980</GSM><GSM>GSM9115981</GSM><GSM>GSM9115982</GSM><GSM>GSM9115960</GSM><GSM>GSM9115983</GSM><GSM>GSM9115961</GSM><GSM>GSM9115966</GSM><GSM>GSM9115967</GSM><GSM>GSM9115968</GSM><GSM>GSM9115969</GSM><GSM>GSM9115962</GSM><GSM>GSM9115984</GSM><GSM>GSM9115985</GSM><GSM>GSM9115963</GSM><GSM>GSM9115986</GSM><GSM>GSM9115964</GSM><GSM>GSM9115965</GSM><GSM>GSM9115959</GSM><GSM>GSM9115970</GSM><GSM>GSM9115971</GSM><GSM>GSM9115972</GSM><GSM>GSM9115977</GSM><GSM>GSM9115955</GSM><GSM>GSM9115956</GSM><GSM>GSM9115978</GSM><GSM>GSM9115979</GSM><GSM>GSM9115957</GSM><GSM>GSM9115958</GSM><GSM>GSM9115951</GSM><GSM>GSM9115973</GSM><GSM>GSM9115974</GSM><GSM>GSM9115952</GSM><GSM>GSM9115975</GSM><GSM>GSM9115953</GSM><GSM>GSM9115976</GSM><GSM>GSM9115954</GSM><GPL>24676</GPL><GSE>303020</GSE><taxon>Homo sapiens</taxon><PMID>[42292443]</PMID></cross_references></HashMap>